| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.079 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |